Kazia Therapeutics Ltd banner

Kazia Therapeutics Ltd
F:NV9

Watchlist Manager
Kazia Therapeutics Ltd Logo
Kazia Therapeutics Ltd
F:NV9
Watchlist
Price: 0.7 EUR Market Closed
Market Cap: €104.7m

Intrinsic Value

NV9 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.
NV9 doesn't have a meaningful market cap.

The intrinsic value for Kazia Therapeutics Ltd (NV9) under the Base Case is 0.16 EUR. Compared with the current market price of 0.7 EUR, the stock appears Overvalued by 78% .

Intrinsic value calculated using DCF
€0.16

Do our valuations actually work? See backtest results .

NV9 Intrinsic Value
0.16
Overvaluation 78%
Intrinsic Value
Price €0.7
Monitor NV9
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.13
Get notified when the price drops into your buy zone
Current Price €0.7
Intrinsic Value €0.16
Margin of Safety 20% €0.13
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about NV9?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NV9 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kazia Therapeutics Ltd.

Explain Valuation
Alternatives to NV9

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one NV9 stock?

The intrinsic value for Kazia Therapeutics Ltd (NV9) under the Base Case is 0.16 EUR.

Is NV9 stock undervalued or overvalued?

Compared with the current market price of 0.7 EUR, the stock appears Overvalued by 78% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett